Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 33 - Antiparasitic agents
Patents for A61P 33 - Antiparasitic agents (21,787)
12/2003
12/02/2003US6656936 Growth inhibitors of Candida albicans, and anti-HIV agents
12/02/2003US6656907 Method of treating gastric ulcer by administration of epidermal growth factor
12/02/2003US6656905 Cyclic tetrapeptide compound and use thereof
12/02/2003US6656504 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
12/02/2003US6656479 Protects a mammal against neosporosis
12/02/2003US6656462 Interleukin-1 muteins useful as vaccine adjuvants
11/2003
11/27/2003WO2003097679A1 Cystic echinococcosis protein and uses therefor
11/27/2003WO2003097665A2 Mid 241 receptor, a novel g-protein coupled receptor
11/27/2003WO2003097659A1 6-11 bicyclic ketolide derivatives
11/27/2003WO2003097605A1 Pesticidal pyridinecarboxamide derivatives
11/27/2003WO2003097604A1 Pyridine carboxamide derivatives and their use as pesticides
11/27/2003WO2003097597A2 Indole derivatives and the use thereof as cb2 receptor ligands
11/27/2003WO2003097591A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
11/27/2003WO2003097585A2 Amidoacetonitrile compounds
11/27/2003WO2003097109A1 Improvements in delivery technology
11/27/2003WO2003097104A1 Treatment and prevention of tissue damage
11/27/2003WO2003097091A2 Glucan-based vaccines
11/27/2003WO2003097062A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003WO2003097052A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/27/2003WO2003097040A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003WO2003097036A1 N-acylaminoacetonitrile derivatives and their use for controlling parasites
11/27/2003WO2003097009A1 Injection formulation
11/27/2003WO2003096989A2 Anti tubercular drug: compositions and methods
11/27/2003WO2003078361B1 Controlling chemical reactions by spectral chemistry and spectral conditioning
11/27/2003WO2003066807A9 Method of inhibiting pathogenicity of infectious agents
11/27/2003WO2003059881A3 Dna minor groove binding compounds
11/27/2003WO2003035696A3 Humanized antibodies against icam-1, their production and uses
11/27/2003WO2003035651A3 Novel artemisinine derivatives, and uses thereof for treating malaria
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2003006425A3 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
11/27/2003WO2003005971A3 Tetracycline compounds having target therapeutic activities
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003US20030220373 Therapeutic uses of PPAR mediators
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219458 Multivalent vaccination using recombinant adenovirus
11/27/2003US20030219438 Human antibodies that bind human TNFalpha
11/27/2003CA2830619A1 Glucan-based vaccines
11/27/2003CA2794297A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione or 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione for treatment and management of amyloidosis
11/27/2003CA2794060A1 Methods and compositions using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione for treatment and management of multiple myeloma
11/27/2003CA2752140A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-1-yl)-piperidine-2,6-dione for treatment and management of renal cancer
11/27/2003CA2752127A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of hepatocellular carcinoma
11/27/2003CA2752124A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of head and neck cancer
11/27/2003CA2752122A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of ovarian cancer
11/27/2003CA2727830A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of multiple myeloma
11/27/2003CA2727824A1 Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment and management of solid tumors
11/27/2003CA2486468A1 Improvements in delivery technology
11/27/2003CA2486465A1 Amidoacetonitrile compounds
11/27/2003CA2486141A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
11/27/2003CA2486133A1 Injection formulation
11/27/2003CA2485847A1 Glucan-based vaccines
11/27/2003CA2485592A1 Anti tubercular drug: compositions and methods
11/27/2003CA2484631A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003CA2483286A1 N-acylaminoacetonitrile derivatives and their use for controlling parasites
11/27/2003CA2482756A1 Indole derivatives and the use thereof as cb<sb>2</sb> receptor ligands
11/26/2003EP1364010A2 Immunomodulatory polynucleotides and methods of using the same
11/26/2003EP1363930A1 A method for generating genetically altered antigens
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363881A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2003EP1363654A2 Fab i and inhibition of apicomplexan parasites
11/26/2003EP1363637A1 Pyrimidine compounds and methods for making and using the same
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1119559B1 3-phenyl-pyrones
11/26/2003EP1028977B1 Bifidus stimulating peptides and their uses
11/26/2003EP0828487B1 Agents for use against parasitic protozoa
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458923A Substituted amino-aza-cycloalkanes useful against malaria
11/25/2003US6653347 For therapy
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
11/25/2003US6653281 Ring modified cyclic peptide analogs
11/20/2003WO2003095498A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003WO2003095459A2 Alkaloid-derived compounds and use thereof in cancer and malaria treatment
11/20/2003WO2003095398A2 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
11/20/2003WO2003094911A1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
11/20/2003WO2003054012A3 Leptin proteins
11/20/2003WO2003008444A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/20/2003WO2003000864A3 Nucleic acid-associated proteins
11/20/2003WO2002090530A3 Kinases and phosphatases
11/20/2003WO2002066048A8 Crystal modification of a cyclic depsipeptide having improved strength
11/20/2003WO2002033050A8 Methods and compositions for promoting the maturation of monocytes
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003US20030215921 Vascular endothelial growth factor-2
11/20/2003US20030215829 Nuclear hormone receptors
11/20/2003US20030215496 Solid carrier includes a hydrophililc surfactant and a drug
11/20/2003US20030215452 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules
11/20/2003CA2485167A1 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
11/20/2003CA2484835A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/19/2003EP1362598A1 Active oxygen generator containing photosensitizer for ultrasonic therapy
11/19/2003EP1362583A1 Process for masking the taste of substances by microencapsulation
11/19/2003EP1362061A2 Antibodies that bind both bcma and taci
11/19/2003EP1362052A1 Inhibitors of cruzipain and other cysteine proteases
11/19/2003EP1362046A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
11/19/2003EP1362042A1 Cyclic 2-carbonylaminoketones as inhibitors of cruzipain and other cysteine proteases
11/19/2003EP1086124B1 Novel cyclosporins
11/19/2003CN1456341A Lung clearing oral liquid preparation for treating viral pneumonia in Children and preparing method thereof
11/19/2003CN1456166A Instant biliary ascariasis preparation
11/18/2003US6649797 Contacting protein with a compound that is capable of stable reversible binding with basic amino acid residues of nuclear localization signal of protein for inactivating a nuclear localization signal of a protein
11/18/2003US6649659 Atovaquone pharmaceutical compositions
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
1 ... 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 ... 218